Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Zealand Pharma A/S (ZLDPF : OTC)
 
 • Company Description   
Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended for use in a dual-hormone artificial pancreas system for better hypoglycemia control and diabetes management and other earlier-stage clinical and preclinical peptide therapeutics are in clinical stage. Zealand Pharma A/S is based in Copenhagen, Denmark.

Number of Employees: 329

 
 • Price / Volume Information   
Yesterday's Closing Price: $11.14 Daily Weekly Monthly
20 Day Moving Average: 30 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: 0.73
52 Week High: $31.70
52 Week Low: $11.14
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.11% -19.02%
12 Week -22.34% -14.62%
Year To Date -49.46% -38.24%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Sydmarken 11 Soborg
-
Copenhagen,G7 2860
DNK
ph: 45-8877-3600
fax: 45-8877-3898
investors@zealandpharma.com http://www.zealandpharma.com
 
 • General Corporate Information   
Officers
Emmanuel Dulac - Chief Executive Officer and President
Alf Gunnar Martin Nicklasson - Chairman
Matthew Douglas Dallas - Senior Vice President and Chief Financial Officer
Adam Sinding Steensberg - Executive Vice President;Research & Development; a
Jeffrey Berkowitz - Director

Peer Information
Zealand Pharma A/S (CORR.)
Zealand Pharma A/S (RSPI)
Zealand Pharma A/S (CGXP)
Zealand Pharma A/S (BGEN)
Zealand Pharma A/S (GTBP)
Zealand Pharma A/S (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: K9898X127
SIC: 8880
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 05/25/22
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: 0.73
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/25/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.12
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 18.89%
vs. Previous Quarter: 34.23%
Sales Growth
vs. Year Ago Period: 90.15%
vs. Previous Quarter: 23.53%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -83.54
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -60.97
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 4.23
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - 3.85
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -371.30
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -371.30
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - 5.25
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©